Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-steady-state kinetics of interaction of wild-type and multiple drug-resistant HIV protease with first and second generation inhibitory drugs.

Doklady. Biochemistry and biophysics - 1 Jan 2000

Kuznetsov N A, Kozyr A V, Dronina M A, Smirnov I V, Kaliberda E N, Mikhailova A G, Rumsh L D, Fedorova O S, Gabibov A G, Kolesnikov A V

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Darunavir
Share to Drug Design
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorescent Dyes

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to Indinavir

Share to Sulfonamides

Source

Identifiers

PMID: 22095129
DOI: 10.1134/S1607672911050139

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-steady-state kinetics of interaction of wild-type and multiple drug-resistant HIV protease with first and second generation inhibitory drugs.PMID 22095129Read ↗

Evolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis.Semantic proximity Read ↗

Recent developments in HIV protease inhibitor therapy.Semantic proximity Read ↗

Current and Novel Inhibitors of HIV ProteaseSemantic proximity Read ↗

Structural and dynamical aspects of HIV-1 protease and its role in drug resistance.Semantic proximity Read ↗

Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants.Semantic proximity Read ↗

Pharmacokinetic Parameters of HIV-1 Protease Inhibitors.Semantic proximity Read ↗

Investigation of molecular mechanisms regulating drug-drug interactions in antiretroviral therapySemantic proximity Read ↗

The pharmacokinetics, pharmacodynamics and pharmacogenetics of Dolutegravir and Cobicistat in the treatment of HIVSemantic proximity Read ↗

Binding kinetics of highly mutated HIV-1 subtype C protease inhibition by Lopinavir and Darunavir in the face of altered conformational dynamics.Semantic proximity Read ↗

Discovery of non-nucleoside inhibitors of HIV-1 reverse transcriptase competing with the nucleotide substrate.Semantic proximity Read ↗

Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.Semantic proximity Read ↗

Pharmacokinetics, pharmacodynamics, efficacy and drug resistance selection of injectable long-acting lenacapavir pre-exposure prophylaxis (PrEP) against HIVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.